Global Implantable Drug Delivery Devices Market to Grow at 8.8% CAGR to US$ 21.1 billion by 2018: Transparency Market Research

ALBANY, New York, September 29, 2014 /PRNewswire via COMTEX/ -- ALBANY, New York, September 29, 2014 /PRNewswire/ --

The global implantable drug delivery devices market will notch US$ 21.1 billion by 2018, recording a CAGR of 8.8% from 2012 through 2018, says the report "Implantable Drug Delivery Devices Market - Global Industry Analysis, Size, Share, Trends and Forecast 2012 - 2018" by Transparency Market Research, a U.S.-based market intelligence company.

The market, which stood at US$11.6 billion in 2011, will benefit from an increasing occurrence of cardiovascular diseases, diabetic retinopathy, colorectal cancer, chronic pain conditions, a growing elderly population worldwide, as well as the high prevalence of unwanted pregnancies. These factors are projected to have the highest impact on the implantable drug delivery devices market over the forecast period. Other low-impact, yet equally vital factors that will propel this market include: favorable initiatives by NGOs and governments, a growing demand (and performance of) minimally-invasive surgeries, as well as a rise in the number of registered interventional cardiologists.

Browse and Buy Implantable Drug Delivery Devices Report: http://www.transparencymarketresearch.com/implantable-drug-delivery-devices.html

In addition to growth drivers, the market research report also identifies lucrative growth opportunities for the implantable drug delivery devices market. Participants can explore growth avenues such as biodegradable implantable drug delivery devices and technologies and innovative products in the form of Microchips (especially for conditions such as osteoporosis).

Within implantable drug delivery devices, the largest market share was held by cardiovascular applications as of 2011. The cardiovascular applications segment will further expand with the launch of bio-absorbable stents in 2014, and will thus witness accelerated growth until 2018. In CAGR terms, the biodegradable drug delivery implant technology will overtake the non-biodegradable drug delivery implant technology, as the former does not require additional surgical procedures for device removal, and also purges any side effects that may result from such devices being lodged in the body.

By geographical region, the North American market was the largest in 2011. But, the report estimates that by 2018, the share of North America in the implantable drug delivery devices market will slide. The situation in the Asia Pacific will be quite the opposite, as the market in this region will witness accelerated growth on account of rapidly-emerging nations such as China and India.

Make an Inquiry: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=887

The contraceptive drug delivery implants market holds significance as the adoption rate of various contraceptive products is observed to be high. The largest share in this market was held by Merck - a factor attributed to the popularity of its products such as Implanon Nxt, Implanon, and NuvaRing. Bayer HealthCare comes a close second in the market contraceptive drug delivery implants, propelled by its well-liked hormonal product IUD Mirena. Bayer HealthCare also strengthened its market standing with the launch of IUD Skyla in the United States and hormonal Jaydess in the European market in 2013.

Related and Recent Published Reports by Transparency Market Research

  • Disinfectors Market: http://www.transparencymarketresearch.com/disinfectors-market.html
  • Ablation Technologies Market: http://www.transparencymarketresearch.com/ablation-technologies-market.html
  • Fluoroscopy and Mobile C-arms Market: http://www.transparencymarketresearch.com/fluoroscopy-mobile-c-arm.html

The report segments the global implantable drug delivery devices market on the basis of product types, by application, by technology, and by geography.

By product, the implantable drug delivery devices market is segmented as: Implantable coronary drug eluting stents, implantable contraceptive drug delivery devices, implantable bio-absorbable stents, implantable brachytherapy seeds, implantable intraocular drug delivery devices, implantable Drug Delivery Devices Market by Technology, implantable drug infusion pumps, biodegradable implantable drug delivery device technology, and non-biodegradable implantable drug delivery device technology.

On the basis of applications, the implantable drug delivery devices market is segmented as: Cardiovascular, ophthalmology, contraception/birth control, oncology, and others (diabetes and chronic pain conditions).

The report also studies the market for implantable drug delivery devices by segmenting it into the following geographical regions: Europe, Asia, North America, and Rest of the World.

Browse the full Implantable Drug Delivery Devices Market Press Release: http://www.transparencymarketresearch.com/pressrelease/implantable-drug-delivery-devices.htm

About Us:

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Sheela AK

State Tower, 90 State Street,

Suite 700, Albany NY - 12207

USA/Canada Toll Free: 866-552-3453

Email: [email protected]

Web: http://www.transparencymarketresearch.com/

Blog: http://www.tmrblog.com/

Follow us on Facebook https://www.facebook.com/transparencymarketresearch

Follow us on Twitter https://twitter.com/research_market

Follow us on Linkedin http://www.linkedin.com/company/transparency-market-research

SOURCE Transparency Market Research Pvt. Ltd

Copyright (C) 2014 PR Newswire. All rights reserved

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.